Nicotine Research Consortium Inc
Nicotine Research Consortium: Consistent Spending, Declining Revenue
EIN: 222820327 · Raleigh, NC · NTEE: S41 · Updated: 2026-04-04
Is Nicotine Research Consortium Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Nicotine Research Consortium Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Nicotine Research Consortium Inc
Nicotine Research Consortium Inc (EIN: 222820327) is a nonprofit organization based in Raleigh, NC, classified under NTEE code S41. The organization reported total revenue of $4.3M and total assets of $576K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Nicotine Research Consortium Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Nicotine Research Consortium Inc is a mid-size nonprofit that has been operating for 10 years, with 8 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 6.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $4.4M |
| Total Expenses | $4.9M |
| Surplus / Deficit | $-508,902 |
| Total Assets | $895K |
| Total Liabilities | $970K |
| Net Assets | $-74,854 |
| Operating Margin | -11.7% |
| Debt-to-Asset Ratio | 108.4% |
| Months of Reserves | 2.2 months |
Financial Health Grade: D
In 2023, Nicotine Research Consortium Inc reported a deficit of $509K with expenses exceeding revenue, holds 2.2 months of operating reserves (limited), has a debt-to-asset ratio of 108.4% (high leverage).
Financial Trends
Over 8 years of filings (2010–2023), Nicotine Research Consortium Inc's revenue has grown at a compound annual growth rate (CAGR) of 6.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -7.6% | +3.4% | -38.5% |
| 2022 | +9.9% | +16.8% | +30.0% |
| 2021 | +135.4% | +120.8% | +4.8% |
| 2015 | +0.6% | -1.6% | +4.1% |
| 2014 | -1.1% | +4.2% | -3.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2016 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Nicotine Research Consortium Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Nicotine Research Consortium Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $509K, with expenses exceeding revenue.
- Debt-to-asset ratio: 108.4%.
Executive Compensation Analysis
Executive compensation is reported as $0 across all available filings, which warrants further investigation to understand how leadership is compensated or if this indicates a volunteer-led structure.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Nicotine Research Consortium Inc's IRS 990 filings:
- Consistent reporting of $0 executive compensation across multiple years for an organization with millions in revenue is highly unusual and may indicate incomplete reporting or an unusual operational model.
- Revenue has shown a declining trend from $4,716,916 in 2022 to $4,273,889 in 2023, which could impact future program sustainability.
- The 'l' field (likely liabilities) has shown an increasing trend from $679,539 in 2021 to $970,256 in 2023, which could indicate growing financial obligations.
Strengths
The following positive indicators were identified for Nicotine Research Consortium Inc:
- The organization consistently maintains a healthy asset base, with assets of $576,285 in 2023.
- Expenses have generally remained below revenue, indicating sound financial management in most years.
- The organization has a long operating history, with data available back to 2010, suggesting stability.
Frequently Asked Questions about Nicotine Research Consortium Inc
Is Nicotine Research Consortium Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Nicotine Research Consortium Inc (EIN: 222820327) some concerns. Mission Score: 75/100. 3 red flags identified, 3 strengths noted.
How does Nicotine Research Consortium Inc spend its money?
Nicotine Research Consortium Inc directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Nicotine Research Consortium Inc tax-deductible?
Nicotine Research Consortium Inc is registered as a tax-exempt nonprofit (EIN: 222820327). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What does Nicotine Research Consortium Inc do?
Nicotine Research Consortium Inc is a nonprofit organization in the Community Improvement sector, located in Raleigh, North Carolina. It is classified under NTEE code S41.
How much revenue does Nicotine Research Consortium Inc have?
Nicotine Research Consortium Inc reported total revenue of $4,273,889. Based on 8 IRS 990 filings on record.
What are Nicotine Research Consortium Inc's total assets?
Nicotine Research Consortium Inc holds total assets of $576,285 as reported in IRS 990 filings.
Where is Nicotine Research Consortium Inc located?
Nicotine Research Consortium Inc is based in Raleigh, North Carolina.
What is Nicotine Research Consortium Inc's EIN?
Nicotine Research Consortium Inc's Employer Identification Number (EIN) is 222820327. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Nicotine Research Consortium Inc?
Nicotine Research Consortium Inc is classified under NTEE code S41 (Community Improvement).
Is Nicotine Research Consortium Inc a registered 501(c)(3)?
Yes, Nicotine Research Consortium Inc is recognized as a tax-exempt organization by the IRS. EIN: 222820327.
Does Nicotine Research Consortium Inc file IRS Form 990?
Yes, Nicotine Research Consortium Inc has 8 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was Nicotine Research Consortium Inc's revenue in 2023?
In the 202312 filing period, Nicotine Research Consortium Inc reported total revenue of $4,356,795, total expenses of $4,865,697, and net assets of $895,402.
Is Nicotine Research Consortium Inc's revenue growing or declining?
Nicotine Research Consortium Inc's revenue is declining. Revenue went from $4,716,916 (202212) to $4,356,795 (202312), a -7.6% change. Based on 8 filings on record.
What is Nicotine Research Consortium Inc's most recent 990 filing?
The most recent IRS Form 990 filing for Nicotine Research Consortium Inc covers tax period 202312. It shows revenue of $4,356,795, expenses of $4,865,697, total assets of $895,402, and liabilities of $970,256.
How much does Nicotine Research Consortium Inc spend on programs vs administration?
Based on IRS 990 analysis, Nicotine Research Consortium Inc allocates approximately 85% of expenses to program services, 10% to administrative costs, and 5% to fundraising. This indicates strong program focus.
Is Nicotine Research Consortium Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, Nicotine Research Consortium Inc appears trustworthy. Mission Score: 75/100 (Good). 3 red flags identified. 3 strengths noted.
What are the red flags for Nicotine Research Consortium Inc?
The following concerns were identified: Consistent reporting of $0 executive compensation across multiple years for an organization with millions in revenue is highly unusual and may indicate incomplete reporting or an unusual operational model.. Revenue has shown a declining trend from $4,716,916 in 2022 to $4,273,889 in 2023, which could impact future program sustainability.. The 'l' field (likely liabilities) has shown an increasing trend from $679,539 in 2021 to $970,256 in 2023, which could indicate growing financial obligations.. These flags are based on automated analysis of IRS 990 public filings and should be verified independently.
What are Nicotine Research Consortium Inc's strengths?
Positive indicators for Nicotine Research Consortium Inc include: The organization consistently maintains a healthy asset base, with assets of $576,285 in 2023.. Expenses have generally remained below revenue, indicating sound financial management in most years.. The organization has a long operating history, with data available back to 2010, suggesting stability.. These findings are derived from AI analysis of the organization's financial filings.
How does Nicotine Research Consortium Inc compensate executives?
Executive compensation is reported as $0 across all available filings, which warrants further investigation to understand how leadership is compensated or if this indicates a volunteer-led structure. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
Given the consistent $0 executive compensation, how does Nicotine Research Consortium Inc. attract and retain leadership, and what is the underlying operational model that supports this?
The consistent reporting of $0 executive compensation suggests either a fully volunteer-led executive team, or that compensation is being reported under a different category or through an affiliated entity not reflected in these filings. Further inquiry into their governance structure and compensation policies is needed to understand this model.
What specific programs or initiatives are driving the significant portion of expenses (e.g., $4,865,697 in 2023), and how are these programs measured for effectiveness in achieving the mission?
While the data shows substantial expenses, it lacks the granular detail to identify specific programs. To assess effectiveness, one would need to review program descriptions, target outcomes, and impact reports, which are not available in the provided financial summary.
Filing History
IRS 990 filing history for Nicotine Research Consortium Inc showing financial trends over 8 years of public records:
Over 8 years of IRS 990 filings (2010–2023), Nicotine Research Consortium Inc's revenue has grown by 137.3%, moving from $1.8M to $4.4M. Total assets increased by 1.5% over the same period, from $882K to $895K. Total functional expenses rose by 189.9%, from $1.7M to $4.9M. In its most recent filing year (2023), Nicotine Research Consortium Inc reported a deficit of $509K, with expenses exceeding revenue. The organization holds $970K in liabilities against $895K in assets (debt-to-asset ratio: 108.4%), resulting in net assets of $-74,854.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $4.4M | $4.9M | $895K | $970K | — | — |
| 2022 | $4.7M | $4.7M | $1.5M | $1.0M | — | View 990 |
| 2021 | $4.3M | $4.0M | $1.1M | $680K | — | View 990 |
| 2015 | $1.8M | $1.8M | $1.1M | $810K | — | — |
| 2014 | $1.8M | $1.9M | $1.0M | $765K | — | — |
| 2013 | $1.8M | $1.8M | $1.1M | $764K | — | — |
| 2011 | $1.8M | $1.7M | $968K | $748K | — | — |
| 2010 | $1.8M | $1.7M | $882K | $728K | — | — |
Year-by-Year Financial Summary
- 2023: Revenue of $4.4M, expenses of $4.9M, and assets of $895K (revenue -7.6% year-over-year).
- 2022: Revenue of $4.7M, expenses of $4.7M, and assets of $1.5M (revenue +9.9% year-over-year).
- 2021: Revenue of $4.3M, expenses of $4.0M, and assets of $1.1M (revenue +135.4% year-over-year).
- 2015: Revenue of $1.8M, expenses of $1.8M, and assets of $1.1M (revenue +0.6% year-over-year).
- 2014: Revenue of $1.8M, expenses of $1.9M, and assets of $1.0M (revenue -1.1% year-over-year).
- 2013: Revenue of $1.8M, expenses of $1.8M, and assets of $1.1M (revenue +2.2% year-over-year).
- 2011: Revenue of $1.8M, expenses of $1.7M, and assets of $968K (revenue -2.3% year-over-year).
- 2010: Revenue of $1.8M, expenses of $1.7M, and assets of $882K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Nicotine Research Consortium Inc:
Data Sources and Methodology
This transparency report for Nicotine Research Consortium Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.